Tegaserod Maleate Exerts Anti-Tumor Effects on Prostate Cancer via Repressing Sonic Hedgehog Signaling Pathway

Investigators found that tegaserod maleate, an FDA-approved agent, inhibited proliferation, colony formation, migration as well as invasion, caused the arrest of the cell cycle, and promoted apoptosis of prostate cancer cells in vitro.